| 000 | 04966nam a22003855i 4500 | ||
|---|---|---|---|
| 001 | 100815 | ||
| 003 | ESmaUEC | ||
| 005 | 20230102113012.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 180515s2018 gw | s |||| 0|eng d | ||
| 020 |
_a9783319690759 _9 |
||
| 024 | 7 |
_a10.1007/978-3-319-69075-9 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC |
||
| 050 | 4 | _aQK981 2018 EB | |
| 245 | 1 | 0 |
_aGrand Challenges in Marine Biotechnology _cedited by Pabulo H. Rampelotto, Antonio Trincone. |
| 264 | 1 |
_aCham, Switzerland _bSpringer International Publishing _c2018 |
|
| 300 | _a1 recurso en línea (XX, 616 páginas) | ||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 347 |
_atext file _bPDF _2 |
||
| 490 | 0 |
_aGrand Challenges in Biology and Biotechnology _x2367-1017 |
|
| 505 | 0 | _aPart-1: The Promise of the Blue Biotechnology. The Marine Ecosystem as a Source of Antibiotics.- Seaweeds: Valuable Ingredients for the Pharmaceuticals Industries.- Anti-Infective Compounds from Marine Organisms.- The Marine-Derived Filamentous Fungi in Biotechnology.- Aplysinopsins as Promising Marine Natural Product Drug Leads.- Potential of Hydrogen Fermentative Pathways in Marine Thermophilic Bacteria.- Anaerobic Digestion and Gasification of Seaweed -- Part-2: The Economic Potential of Marine Biotechnology. The Global Market for Marine Biotechnology: The Underwater World of Marine Biotech Firms.- How to Succeed in Marketing Marine Natural Products for Pharmaceutical, Cosmetics and Nutraceutical Markets.- EMBRC and EMBRIC: Two European Instruments to Promote the Blue Bioeconomy -- Part-3: Supporting the Development of Marine Biotechnology. Grand Challenges in Marine Biotechnology: Overview of Recent EU-Funded Projects.- SeaBioTech: From Sea-bed to Test-bed: Harvesting the Potential of Marine Biodiversity for Industrial Biotechnology.- BluePharmTrain: Biology and Biotechnology of Marine Sponges.- ChiBio: An Integrated Bio-Refinery for Processing Chitin Rich Bio-Waste to Specialty Chemicals.- Utilization of Marine Genetic Resources: The Access and Benefit-Sharing Legal Framework. | |
| 520 | 3 | _aThis book serves as essential reading for research scientists and biotechnologists from both academia and industry working in marine biotechnology and related disciplines. The book discusses recent advances and challenges in terms of science, technology, innovation, and policy for the development of the field; and how marine biotechnology may provide new solutions to some of the grand challenges faced by our society. Written in an accessible language, the book is also recommended as a reference text for decision-makers in government and non-governmental organizations in their efforts to foster the development of a global blue economy. With less than 5 % of the vast and rich marine environment explored, our seas and oceans represent a virtually unexplored resource for the discovery of novel product, processes, and development of bio-inspired synthetic drugs with biotechnological potential. As such, the marine environment has been considered Earth's last frontier of exploration. Recent advances in molecular techniques are providing the necessary tools to access on a larger scale the still-untapped ocean resources and, consequently, unveil the promise of the blue biotechnology. Governments are recognizing the potential of marine biotechnology to provide solutions to some of the Grand Challenges of the 21st Century such as sustainable energy and food sources, identification of novel drugs for improved health treatments, and providing new industrial materials and processes. For this reason, advances in marine biotechnology may foster the much-needed source of innovation and economic growth in many countries, and pave the way towards the development of a global blue economy, i.e. a new economic model based on the sustainable exploration of our ocean ecosystems. | |
| 650 | 7 |
_aGenética vegetal _2embne _9139640 |
|
| 650 | 7 |
_aMicrobiología _2embne _9138684 |
|
| 700 | 1 |
_aRampelotto, Pabulo H. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _0http://id.loc.gov/authorities/names/n2016186547 _1http://viaf.org/viaf/2337147786751168220009 _996813 |
|
| 700 | 1 |
_aTrincone, Antonio. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _0http://id.loc.gov/authorities/names/n2006182531 _1http://viaf.org/viaf/1907911 |
|
| 710 | 2 |
_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _1http://viaf.org/viaf/148105729 _9106996 |
|
| 776 | 0 | 8 |
_iEdición impresa: _z9783319690742 |
| 776 | 0 | 8 |
_iEdición impresa: _z9783319690766 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-69075-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 490 | 0 | _aBiomedical and Life Sciences (Springer-11642) | |
| 942 | _2lcc | ||
| 998 |
_aSI _a_alco _a_vill _b03/2019 _cm _dz _ea _feng _ggw _h0 |
||
| 999 |
_c100815 _d100815 _x1 |
||